The most common forms of pediatric tumors are acute leukemia (33%), brain tumors (25%), and lymphomas (15%). Diagnosing these tumors utilizes various tests, including those performed by a pathologist (such as IHC) and those that are platform-based (like NGS). The findings from these tests influence treatment options, and pediatric cancers are increasingly treatable pathologies as advanced therapeutics are now available. Bone marrow transplants, immunotherapy, and genetically modified cells that attack tumors are all examples of these therapeutic options. This event will focus on brain and hematological tumors, including identification of biomarkers, discussion of the testing landscape, and review of potential diagnostic hurdles. 

Webinar agenda:

• 3.00-3.05: Diaceutics and speakers introduction
• 3.05-3.25: Brain tumors – Presentation by Dr. Maura Massimino
• 3.25-3.35 Q&A (All participants).
• 3.35-3.55: Hematological tumors – Presentation by Dr. Olga Weinberg
• 3.55-4:05 Q&A and final discussion (All participants).